Interventional Cardiology
ST-elevation MI treatment and primary PCI
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does fibrinolytic therapy vs placebo improve outcomes in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitfibrinolytic therapy vs placebo · Myocardial Infarction Hospitalization
Does metoprolol vs placebo improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitmetoprolol vs placebo · Myocardial Infarction Hospitalization
Does metoprolol vs placebo improve outcomes in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitmetoprolol vs placebo · Myocardial Infarction Hospitalization
Does anakinra vs placebo improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitanakinra vs placebo · Myocardial Infarction Hospitalization
Does ticagrelor vs clopidogrel improve outcomes in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitticagrelor vs clopidogrel · Myocardial Infarction Hospitalization
Does ticagrelor vs clopidogrel improve outcomes in Acute Coronary Syndrome?
Low Certainty− Favors harmticagrelor vs clopidogrel · Cardiac Output
Does aspirin vs streptokinase improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?
Low Certainty− Favors harmaspirin vs streptokinase · Myocardial Infarction Hospitalization
Does bivalirudin vs heparin, porcine improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?
Low Certainty− Favors harmbivalirudin vs heparin, porcine · Myocardial Infarction Hospitalization
Does aspirin vs rosuvastatin improve Cardiac Output in Acute Coronary Syndrome?
Low Certainty− Favors harmaspirin vs rosuvastatin · Cardiac Output
Does ticagrelor vs clopidogrel improve Cardiac Output in Acute Coronary Syndrome?
Low Certainty− Favors harmticagrelor vs clopidogrel · Cardiac Output
STEMI management (also known as ST elevation MI, primary PCI, STEMI protocol). ST-elevation MI treatment and primary PCI
Synapse tracks 10 specific clinical questions in STEMI management, each synthesized independently from its own trial evidence. They include: "Does fibrinolytic therapy vs placebo improve outcomes in ST segment elevation myocardial infarction?"; "Does metoprolol vs placebo improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?"; "Does metoprolol vs placebo improve outcomes in ST segment elevation myocardial infarction?"; "Does anakinra vs placebo improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?"; "Does ticagrelor vs clopidogrel improve outcomes in ST segment elevation myocardial infarction?".
As of 2026-06-23, the scientific consensus on STEMI management is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/69b0a30eb42209bc31dca33d.
Deterministic synthesis from Synapse's enriched corpus — 142 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every STEMI management paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search STEMI management papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers